MACROGENICS, INC. Other Non-Current Liabilities
MACROGENICS, INC. (MGNX) had Other Non-Current Liabilities of $450.00 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Other than Long-Term Debt, Noncurrent
us-gaap:OtherLiabilitiesNoncurrent · last filed 2026-08-14
- 2026-06-30: Other Liabilities, Noncurrent $450.00K.
- 2026-03-31: Other Liabilities, Noncurrent $727.00K.
- 2025-12-31: Other Liabilities, Noncurrent $1.05M.
- 2025-09-30: Other Liabilities, Noncurrent $1.33M.
| Period end | Other Liabilities, Noncurrent |
|---|---|
| 2026-06-30 | $450.00K 10-Q · filed 2026-08-14 |
| 2026-03-31 | $727.00K 10-Q · filed 2026-05-13 |
| 2025-12-31 | $1.05M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $1.33M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.67M 10-Q · filed 2025-08-14 |
| 2025-03-31 | $1.97M 10-Q · filed 2025-05-13 |
| 2024-12-31 | $1.97M 10-K · filed 2026-03-09 |
| 2024-09-30 | $258.00K 10-Q · filed 2024-11-05 |
| 2024-06-30 | $258.00K 10-Q · filed 2024-08-06 |
| 2024-03-31 | $258.00K 10-Q · filed 2024-05-09 |
| 2023-12-31 | $258.00K 10-K · filed 2025-03-20 |
| 2023-09-30 | $258.00K 10-Q · filed 2023-11-06 |
| 2023-06-30 | $258.00K 10-Q · filed 2023-08-09 |
| 2023-03-31 | $258.00K 10-Q · filed 2023-05-09 |
| 2022-12-31 | $258.00K 10-K · filed 2024-03-07 |
| 2022-09-30 | $258.00K 10-Q · filed 2022-11-03 |
| 2022-06-30 | $258.00K 10-Q · filed 2022-08-08 |
| 2022-03-31 | $258.00K 10-Q · filed 2022-05-03 |
| 2021-12-31 | $258.00K 10-K · filed 2023-03-15 |
| 2021-09-30 | $258.00K 10-Q · filed 2021-11-02 |
| 2021-06-30 | $258.00K 10-Q · filed 2021-07-29 |
| 2021-03-31 | $258.00K 10-Q · filed 2021-04-29 |
| 2020-12-31 | $0.00 10-K · filed 2022-02-24 |
| 2020-09-30 | $2.25M 10-Q · filed 2020-11-04 |
| 2020-06-30 | $1.44M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $515.00K 10-Q · filed 2020-05-05 |
| 2019-12-31 | $0.00 10-Q · filed 2020-11-04 |
| 2016-09-30 | $727.00K 10-Q · filed 2016-11-02 |
| 2016-06-30 | $727.00K 10-Q · filed 2016-08-03 |
| 2016-03-31 | $727.00K 10-Q · filed 2016-05-04 |
| 2015-12-31 | $0.00 10-Q · filed 2016-11-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |